In the late 1980s, a promising new treatment for breast cancer emerged: high-dose chemotherapy with autologous bone marrow transplantation or HDC/ABMT. By the 1990s, it had burst upon the oncology scene and disseminated rapidly before having been carefully evaluated. By the time published studies showed that the procedure was ineffective, more than 30,000 women had received the treatment, shortening their lives and adding to their suffering. This book tells of the rise and demise of HDC/ABMT for metastatic and early stage breast cancer, and fully explores the story's implications, which go well beyond the immediate procedure, and beyond breast cancer, to how we in the United States evaluate other medical procedures, especially life-saving ones.
It details how the factors that drove clinical use--patient demand, physician enthusiasm, media reporting, litigation, economic exploitation, and legislative and administrative mandates--converged to propel the procedure forward despite a lack of proven clinical effectiveness. It also analyzes the limited effect of technology assessments before randomized clinical trials evaluated decisively the procedure and the ramifications of this system on healthcare today.
Sections of the book consider the initial conditions surrounding the emergence of the new breast cancer treatment, the drivers of clinical use, and the struggle for evidence-based medicine. A concluding section considers the significance of the story for our healthcare system.
"synopsis" may belong to another edition of this title.
Richard Rettig is an Adjunct Senior Social Scientist at RAND Corporation in Arlington, Virginia. Peter Jacobson is Director of the Center for Law, Ethics, and Health at the University of Michigan School of Public Health in Ann Arbor. Cynthia Farquhar is a Postgraduate Professor of Obstetrics and Gynaecology at the University of Auckland in New Zealand. Wade Aubry is an Associate Clinical Professor of Medicine at the UCSF Institute for Health Policy Studies.
"About this title" may belong to another edition of this title.
Seller: ThriftBooks-Atlanta, AUSTELL, GA, U.S.A.
Hardcover. Condition: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less. Seller Inventory # G0195187768I4N00
Seller: Better World Books, Mishawaka, IN, U.S.A.
Condition: Good. 1st. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good. Seller Inventory # 15401634-6
Seller: HPB Inc., Dallas, TX, U.S.A.
Hardcover. Condition: Very Good. Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority! Seller Inventory # S_465239731
Seller: Unique Books, Lexington, KY, U.S.A.
Hardcover. Condition: Fine. Dust Jacket Condition: Near Fine. 1st Edition. b-780. Seller Inventory # b-506-02-jn
Seller: GoldBooks, Denver, CO, U.S.A.
Hardcover. Condition: new. New Copy. Customer Service Guaranteed. Seller Inventory # 32A74_93_0195187768
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New. Seller Inventory # 4255959-n
Seller: BennettBooksLtd, Los Angeles, CA, U.S.A.
hardcover. Condition: New. In shrink wrap. Looks like an interesting title! Seller Inventory # Q-0195187768
Seller: Brook Bookstore On Demand, Napoli, NA, Italy
Condition: new. Questo è un articolo print on demand. Seller Inventory # eeaa78bd78add0e43d7027582f5159e0
Quantity: Over 20 available
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
HRD. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L1-9780195187762
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition. Seller Inventory # 4255959